Market Cap 3.25B
Revenue (ttm) 158.32M
Net Income (ttm) -68.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 20.93
Profit Margin -43.53%
Debt to Equity Ratio 4.28
Volume 1,314,600
Avg Vol 1,992,840
Day's Range N/A - N/A
Shares Out 88.11M
Stochastic %K 29%
Beta 0.52
Analysts Strong Sell
Price Target $49.89

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
Doom_Gloom_AR
Doom_Gloom_AR Mar. 21 at 1:09 AM
$LQDA guys cheer up opex is past us, citadel will let it run Monday.
0 · Reply
msgu1021
msgu1021 Mar. 20 at 8:43 PM
$MNKD Market cap is 760 Million vs $LQDA market cap 3.2 billion. Holly mucker -foocker !
1 · Reply
SteelerJon
SteelerJon Mar. 20 at 12:43 AM
$LQDA 😎🏦🏦
0 · Reply
BullRun4
BullRun4 Mar. 19 at 1:23 AM
$LQDA We are just a few days away from the judge’s verdict. May be this Friday or Monday of next week.
2 · Reply
grampslol
grampslol Mar. 18 at 12:57 AM
$MNKD update on $UTHR tyfizzle dpi from $MNKD , #coughcough , So uthr going SMI way $LQDA wins dpi !
0 · Reply
judgeyoung2
judgeyoung2 Mar. 17 at 8:05 PM
$LQDA getting ridiculous at this point
1 · Reply
SuperGreenToday
SuperGreenToday Mar. 17 at 7:05 PM
$LQDA Share Price: $36.85 Contract Selected: Apr 10, 2026 $35 Calls Buy Zone: $3.40 – $4.20 Target Zone: $6.42 – $7.85 Potential Upside: 78% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Biotechnologie
Biotechnologie Mar. 17 at 1:51 PM
$LQDA Has anyone read anything about a major expansion of Yutrepia through a large PBM or provider network? Saw it posted on X, now it's deleted. Strange.
0 · Reply
Ms_P
Ms_P Mar. 17 at 12:35 PM
$ABEO it’s true that it’s not an easy feat to get a treatment FDA approved (especially in the last year), but the company then needs to execute and deliver sales. The difference between a non-profit research institute and for-profit public company. I believe that they will get there, but compared with other launches of in demand products ($LQDA) the launch has been frustrating. Why didn’t they plan better for the assay problems? A for profit company should have done better with their first product launch.
1 · Reply
SteelerJon
SteelerJon Mar. 17 at 12:07 AM
$LQDA 😎🏦🏦
0 · Reply
Latest News on LQDA
Liquidia Analysts Boost Their Forecasts After Q4 Earnings

Mar 6, 2026, 11:17 AM EST - 15 days ago

Liquidia Analysts Boost Their Forecasts After Q4 Earnings


Liquidia Corporation (LQDA) Q4 2025 Earnings Call Transcript

Mar 5, 2026, 10:35 AM EST - 16 days ago

Liquidia Corporation (LQDA) Q4 2025 Earnings Call Transcript


Liquidia Appears Set For Strong 2026 On Further Share Gains

Feb 27, 2026, 7:05 AM EST - 22 days ago

Liquidia Appears Set For Strong 2026 On Further Share Gains


Liquidia Corporation: Heading In The Right Direction

Nov 5, 2025, 6:16 PM EST - 4 months ago

Liquidia Corporation: Heading In The Right Direction


Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:16 PM EST - 4 months ago

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript


Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 13, 2025, 2:51 PM EDT - 7 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results


Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 2:25 PM EDT - 7 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?


Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 12:43 PM EDT - 7 months ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript


What Next For Liquidia After Launch?

Jun 30, 2025, 10:40 AM EDT - 9 months ago

What Next For Liquidia After Launch?


These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 11:08 AM EDT - 10 months ago

These Analysts Boost Their Forecasts On Liquidia


Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 11 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript


Arquitos Capital's Largest Holdings  For Q1 2025

Apr 30, 2025, 9:30 AM EDT - 11 months ago

Arquitos Capital's Largest Holdings  For Q1 2025


Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:56 AM EDT - 1 year ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript


Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:40 PM EST - 1 year ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript


Doom_Gloom_AR
Doom_Gloom_AR Mar. 21 at 1:09 AM
$LQDA guys cheer up opex is past us, citadel will let it run Monday.
0 · Reply
msgu1021
msgu1021 Mar. 20 at 8:43 PM
$MNKD Market cap is 760 Million vs $LQDA market cap 3.2 billion. Holly mucker -foocker !
1 · Reply
SteelerJon
SteelerJon Mar. 20 at 12:43 AM
$LQDA 😎🏦🏦
0 · Reply
BullRun4
BullRun4 Mar. 19 at 1:23 AM
$LQDA We are just a few days away from the judge’s verdict. May be this Friday or Monday of next week.
2 · Reply
grampslol
grampslol Mar. 18 at 12:57 AM
$MNKD update on $UTHR tyfizzle dpi from $MNKD , #coughcough , So uthr going SMI way $LQDA wins dpi !
0 · Reply
judgeyoung2
judgeyoung2 Mar. 17 at 8:05 PM
$LQDA getting ridiculous at this point
1 · Reply
SuperGreenToday
SuperGreenToday Mar. 17 at 7:05 PM
$LQDA Share Price: $36.85 Contract Selected: Apr 10, 2026 $35 Calls Buy Zone: $3.40 – $4.20 Target Zone: $6.42 – $7.85 Potential Upside: 78% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Biotechnologie
Biotechnologie Mar. 17 at 1:51 PM
$LQDA Has anyone read anything about a major expansion of Yutrepia through a large PBM or provider network? Saw it posted on X, now it's deleted. Strange.
0 · Reply
Ms_P
Ms_P Mar. 17 at 12:35 PM
$ABEO it’s true that it’s not an easy feat to get a treatment FDA approved (especially in the last year), but the company then needs to execute and deliver sales. The difference between a non-profit research institute and for-profit public company. I believe that they will get there, but compared with other launches of in demand products ($LQDA) the launch has been frustrating. Why didn’t they plan better for the assay problems? A for profit company should have done better with their first product launch.
1 · Reply
SteelerJon
SteelerJon Mar. 17 at 12:07 AM
$LQDA 😎🏦🏦
0 · Reply
judgeyoung2
judgeyoung2 Mar. 16 at 9:00 PM
$LQDA my money is on a ruling this week…. and it’s totally not like i’ve thought this the last 2 months as well 😅
1 · Reply
Hamboning1
Hamboning1 Mar. 16 at 7:44 PM
$LQDA it sounds like a painful experience to be long LQDA and wake up everyday knowing your stock is going to drop. Just buy puts to help alleviate that pain
1 · Reply
Ceherring
Ceherring Mar. 16 at 9:42 AM
0 · Reply
BullRun4
BullRun4 Mar. 14 at 8:29 PM
$LQDA $40+ very soon
0 · Reply
BullRun4
BullRun4 Mar. 14 at 8:14 PM
$LQDA https://x.com/tgod01/status/2032843212662968711?s=46
0 · Reply
Hamboning1
Hamboning1 Mar. 13 at 6:07 PM
$LQDA Once again, another LQDA spike turned red. Given the massive bearish options flow today, I think we see $29 sooner than later.
1 · Reply
stevemano
stevemano Mar. 13 at 2:10 PM
$GS short with both fists! $LQDA bubbles
0 · Reply
Investor6
Investor6 Mar. 13 at 10:54 AM
Shay Capital holds positions in $TLYS $GRPN $FTAI $PCT $LQDA . Also, in BBBY, where they have sent a letter to the management requiring action about tZero etc. The new CEO of BBBY, Marcus Lemonis took action. In late 2025, Shay Capital sent also a letter to BARK Inc, asking for buybacks etc and proposed Nachum Klugman for the BoD. Later in 2026, N.Klugman through GNK co-operated with M.Lemonis to make a buy-out proposal for BARK at $1.10/share (current sp ~$0.80). Obviously Shay is connected with Klugman but also with Lemonis, after their involvement in BBBY. In the next weeks the BARK special committee will have to decide if they accept the $1.10 offer. If they don't, despite the current high premium, then the group can make a tender offer, as the 75% of the shares are held by institutions and retail investors. The arbitrage is 37%, offering a decent risk/reward ratio. Also, other actions by BARK, like the CIC agreement of the CEO & the payment of the convertibles indicate a buyout.
0 · Reply
stevemano
stevemano Mar. 12 at 10:00 PM
$LQDA https://youtube.com/shorts/fqPJ5Qo3PWY?si=9kgfJkYm3QT5IFq_ News update
0 · Reply
Hamboning1
Hamboning1 Mar. 12 at 5:29 PM
$LQDA As I’ve said many times now, any gains made with LQDA will always be short-lived. IMO this is a good time to pick up puts if you’re into free money
2 · Reply
judgeyoung2
judgeyoung2 Mar. 12 at 5:27 PM
$LQDA he’s alive at least
1 · Reply
JFais
JFais Mar. 12 at 12:05 PM
$LQDA- Where do they get these guys from 😂
0 · Reply